Aesthetics invites MHRA to attend ACE
The Medicines and Healthcare product Regulatory Agency (MHRA) has been invited by Aesthetics to attend the annual ACE 2023 on March 10-11 at the Business Design Centre, London.
The Medicines and Healthcare product Regulatory Agency (MHRA) has been invited by Aesthetics to attend the annual ACE 2023 on March 10-11 at the Business Design Centre, London.
The Medicines and Healthcare products Regulatory Agency (MHRA) has announced a consultation on how the agency engages with healthcare professionals regarding medicines and medical devices.
The Advertising Standards Authority’s (ASA) Committee of Advertising Practice (CAP) has issued an enforcement notice against the advertising of a hay fever treatment injection in the UK.
The British College of Aesthetic Medicine (BCAM) has released a new initiative to engage with other organisations and associations in the sector.
The Medicines and Healthcare products Regulatory Agency (MHRA) has revealed that models of Top-Q dermal filler are being sold with a falsely applied CE Mark.
Representatives from the Medicines and Healthcare product Regulatory Agency (MHRA) will be visiting ACE 2020 on March 13 and 14.
The Medicines and Healthcare products Regulatory Agency (MHRA) has released an alert for practitioners to stop using the Dermapen 3 device, the Dermapen 3 needle tips and the Dermapen Cryo device due to potential risk of injury or infection.
On June 24, the British Association of Aesthetic Plastic Surgeons (BAAPS) released a statement following a television show aired on Channel 4, Dispatches, that questioned the safety of breast implants.
Senior medical device specialist Feza Haque and special projects manager Mitul Jadeja explore the importance of Yellow Card reporting